IM Cannabis Corp.
-80.9% · 90d
$0.28
-0.01 (-2.61%)
News
(1)March 2026
IM Cannabis Corp. — 20-F Filing
IMCCIM Cannabis Corp.
# 🧾 What This Document Is This is IM Cannabis Corp.'s **annual report (Form 20-F)** for the year ended December 31, 2025. It's a comprehensive filing required by the U.S. SEC for foreign companies listed on American exchanges. Think of it as the company's official "year in review" and health check-
Read summaryView on SEC EDGAR
Peers in Drug Manufacturers - Specialty & Generic
TAK#1
Takeda Pharmaceutical Company Limited
$57.78B-1.07%
ZTS#2
Zoetis Inc.
$50.46B+0.20%
HLN#3
Haleon plc
$43.61B+0.40%
TEVA#4
Teva Pharmaceutical Industries Limited
$36.05B+1.44%
UTHR#5
United Therapeutics Corporation
$25.19B-1.19%
VTRS#6
Viatris Inc.
$15.85B+0.29%
RGC#7
Regencell Bioscience Holdings Limited
$13.93B-2.46%
NBIX#8
Neurocrine Biosciences, Inc.
$13.21B-1.13%
ELAN#9
Elanco Animal Health Incorporated
$11.66B-0.59%
RDY#10
Dr. Reddy's Laboratories Limited
$10.92B+0.15%